Fig. 1From: A comprehensive study of the rare diseases and conditions targeted by orphan drug designations and approvals over the forty years of the Orphan Drug ActTotal orphan drug designations (n = 6340) and initial orphan drug approvals (n = 882) by decade, 1983–2022Back to article page